The White House Office of Information and Regulatory Affairs recently released a healthcare agenda to serve as a roadmap for the types of issues and regulatory changes federal agencies aim to address in the coming months.
The Department of Health and Human Services (HHS) listed 188 rules that agencies, such as the Centers for Medicare and Medicaid (CMS) and the Food and Drug Administration (FDA), will be prioritizing. These include, but are not limited to, the following:
- Update the bidding process for Medicare Part D
- Expand oversight of state-managed health insurance exchanges
- Revise federal anti-kickback protections
- Allow state Medicaid programs to charge low-income beneficiaries premiums and co-payments
- Revisit patient privacy rules for those receiving mental healthcare or substance abuse treatment
Prior to this announcement, a senior administration official reported the current administration's deregulation efforts reduced regulatory costs by $33 billion by eliminating 176 rules deemed ineffective since President Trump took office. On the other hand, regulatory advocates have criticized the administration for eliminating certain regulations with societal benefits, such as those that combat climate change and improve air and water quality.
To view a complete list of rules HHS plans to create or address, please click here.
For more information on this topic, or to learn how Baker Tilly healthcare specialists can help, contact our team.
Let us be your source for monthly updates on the ever-evolving healthcare industry. From legislative changes to policy updates, we’ve got you covered.